Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer
Sponsor: Ottawa Hospital Research Institute
Summary
After breast cancer patients complete the acute phase of their treatment (i.e. surgery, chemotherapy and/or radiation therapy), they are routinely followed in clinic every 3-6 months for several years. Multiple guideline recommendations exist with no consensus on the optimal follow-up schedule due to lack of randomized data to support any particular follow-up recommendation. Therefore the investigators propose a randomized trial evaluating personalized vs guideline-based well follow-up strategies for patients with early-stage breast cancer.
Official title: A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer (REaCT-Wellness)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
261
Start Date
2022-08-19
Completion Date
2025-08-15
Last Updated
2026-07-08
Healthy Volunteers
No
Conditions
Interventions
On-demand personalized follow-up care
On-demand personalized follow-up care (on demand access to a WBCP nurse and an annual follow-up by telephone.
Guideline-based follow-up care (standard of care)
Follow-up care based on current standard of care guidelines.
Locations (1)
The Ottawa Hospital Cancer Centre
Ottawa, Ontario, Canada